Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guy Haegeman

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
Endocrine Reviews|August 16, 2003
The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repressionKarolien De Bosscher, Wim Vanden Berghe, Guy Haegeman
Plos One|February 7, 2009
Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammationLaurent Reber, Linda Vermeulen, Guy Haegeman, et al.
Molecular Neurobiology|March 23, 2011
Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectivesAnne Matthys, Guy Haegeman, Kathleen Van Craenenbroeck, et al.
The Journal of Biological Chemistry|February 28, 2008
BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligasePieter Rondou, Guy Haegeman, Peter Vanhoenacker, et al.
FEBS Letters|December 17, 2003
Orientation-dependent gene expression with Epstein-Barr virus-derived vectorsKathleen Van Craenenbroeck, Peter Vanhoenacker, Inge Roman, et al.
Cellular Signalling|August 29, 2006
Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3kKim De Martelaere, Béatrice Lintermans, Guy Haegeman, et al.
Biochemical Pharmacology|August 18, 2004
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapyNathalie Dijsselbloem, Wim Vanden Berghe, An De Naeyer, et al.
Molecular Carcinogenesis|October 14, 2014
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cellsHyeRan Gwak, Guy Haegeman, Benjamin K Tsang, et al.
Journal of Cancer Prevention|January 7, 2016
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in SkinAnna Klopot, Gleb Baida, Pankaj Bhalla, et al.
Cellular Signalling|January 17, 2012
RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradationAnne Matthys, Kathleen Van Craenenbroeck, Béatrice Lintermans, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
Endocrine Reviews|August 16, 2003
The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: molecular mechanisms for gene repressionKarolien De Bosscher, Wim Vanden Berghe, Guy Haegeman
Plos One|February 7, 2009
Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammationLaurent Reber, Linda Vermeulen, Guy Haegeman, et al.
Molecular Neurobiology|March 23, 2011
Role of the 5-HT7 receptor in the central nervous system: from current status to future perspectivesAnne Matthys, Guy Haegeman, Kathleen Van Craenenbroeck, et al.
The Journal of Biological Chemistry|February 28, 2008
BTB Protein KLHL12 targets the dopamine D4 receptor for ubiquitination by a Cul3-based E3 ligasePieter Rondou, Guy Haegeman, Peter Vanhoenacker, et al.
FEBS Letters|December 17, 2003
Orientation-dependent gene expression with Epstein-Barr virus-derived vectorsKathleen Van Craenenbroeck, Peter Vanhoenacker, Inge Roman, et al.
Cellular Signalling|August 29, 2006
Novel interaction between the human 5-HT7 receptor isoforms and PLAC-24/eIF3kKim De Martelaere, Béatrice Lintermans, Guy Haegeman, et al.
Biochemical Pharmacology|August 18, 2004
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections. Multi-purpose nutraceuticals at the crossroad of hormone replacement, anti-cancer and anti-inflammatory therapyNathalie Dijsselbloem, Wim Vanden Berghe, An De Naeyer, et al.
Molecular Carcinogenesis|October 14, 2014
Cancer-specific interruption of glucose metabolism by resveratrol is mediated through inhibition of Akt/GLUT1 axis in ovarian cancer cellsHyeRan Gwak, Guy Haegeman, Benjamin K Tsang, et al.
Journal of Cancer Prevention|January 7, 2016
Selective Activator of the Glucocorticoid Receptor Compound A Dissociates Therapeutic and Atrophogenic Effects of Glucocorticoid Receptor Signaling in SkinAnna Klopot, Gleb Baida, Pankaj Bhalla, et al.
Cellular Signalling|January 17, 2012
RhoBTB3 interacts with the 5-HT7a receptor and inhibits its proteasomal degradationAnne Matthys, Kathleen Van Craenenbroeck, Béatrice Lintermans, et al.
Pageof 11